Drug Discovery and Development on Pma1, Where Are We Now? A Critical Review from 1995 to 2022

Plasma membrane H+‐ATPase (Pma1) is an enzyme uniquely found in plants and fungi. The enzyme controls the nutrient uptake of plants and fungi via an electrochemical gradient processes, which is essential for their survival. Inhibiting Pma1, therefore, constitutes an alternative antifungal target voi...

Full description

Saved in:
Bibliographic Details
Published in:ChemMedChem 2022-10, Vol.17 (19), p.e202200356-n/a
Main Authors: Tung, Truong‐Thanh, Nielsen, John
Format: Article
Language:English
Subjects:
Antifungal agents
Antifungal Agents - pharmacology
Cell Membrane - metabolism
Drug design
Drug Discovery
Fungi
Humans
Pma1
Proton-Translocating ATPases - metabolism
Saccharomyces cerevisiae
Saccharomyces cerevisiae Proteins - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Plasma membrane H+‐ATPase (Pma1) is an enzyme uniquely found in plants and fungi. The enzyme controls the nutrient uptake of plants and fungi via an electrochemical gradient processes, which is essential for their survival. Inhibiting Pma1, therefore, constitutes an alternative antifungal target void of toxicity to humans. From a medicinal chemistry point of view, this review provides a first summary of the recent drug design, synthesis, evaluation, and discovery of molecules targeting Pma1 for 25 years from 1995 to 2022. A key antifungal target: Plasma membrane H+‐ATPase (Pma1) is an enzyme uniquely found in plants and fungi, and is essential for their survival. Inhibiting Pma1 is an alternative antifungal strategy that would avoid toxicity to humans. This review provides the first summary of the design, synthesis, evaluation, and discovery of compounds targeting Pma1 over the past quarter century.
ISSN:1860-7179
1860-7187
DOI:10.1002/cmdc.202200356